According to a recent LinkedIn post from Mandolin, the company engaged with industry participants at the National Home Infusion Association (NHIA) event, emphasizing it as a strong forum for connecting with infusion operators. The post notes appreciation for NHIA organizers and highlights that conversations were focused on meaningful industry interactions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests growing industry momentum around automating access and intake workflows so patients can begin therapy more quickly. For investors, this emphasis on workflow automation in home infusion may indicate Mandolin’s interest in aligning its offerings with efficiency-focused trends, potentially positioning the company to benefit from increased adoption of digital and automated solutions in the infusion therapy ecosystem.
As shared in the LinkedIn post, Mandolin appears to view the current environment as an inflection point for making access and intake automation “real” across the industry. If the company is actively developing or deploying solutions in this area, sustained engagement with influential operators and associations like NHIA could enhance its visibility, support business development opportunities, and strengthen its competitive footing in the broader healthcare technology and services market.